OptiNose Inc (DELISTED) (OPTN:DL)
9.60
0.00 (0.00%)
USD |
NASDAQ |
May 23, 16:00
OptiNose Shareholders Equity (Quarterly) : -61.37M for March 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Akoya Biosciences Inc (DELISTED) | -5.889M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Cassava Sciences, Inc. | 81.57M |
| Aptevo Therapeutics, Inc. | 17.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.85M |
| Total Liabilities (Quarterly) | 176.22M |
| Debt to Equity Ratio | -2.073 |
| Current Ratio | 0.64 |
| Net Debt Paydown Yield | 0.65% |